Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873595 · ClinicalTrials.gov registry record
Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease
A clinical trial, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Terminated
- Registry status
- 29
- Enrollment target
NCT05873595: Clinical Trial study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT05873595 is a clinical trial that was terminated before completion, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05873595 was terminated before completion, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-06-20 |
| Est. Completion | 2024-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05873595
The ClinicalTrials.gov registry entry for NCT05873595 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05873595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05873595 about?
NCT05873595 is a clinical study titled "Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease". This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.
What is the current status of trial NCT05873595?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2023-06-20. Estimated completion is 2024-02-26.
Who is sponsoring clinical trial NCT05873595?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.